US 8,334,278 B2Granted

Use of 3-methoxy-pregnenolone for the preparation of a drug for treating depressive disorders and long-term neurological diseases

AssigneeMapreg

InventorsEtienne-Emile Baulieu, Ester Fellous, Paul Robel, Massimiliano Bianchi

Life of this patent

Estimating the term…

Abstract

The invention relates to the therapeutic use of pregnenolone derivatives for treating depressive disorders and long-term neurological diseases.

Claims4

Dependent claims

A method for the treatment of a depressive disorder in a patient in need thereof, comprising administering to said patient an effective quantity of 3β-methoxy-pregna-5-ene-20-one (3β-methoxy-PREG).

Dependencies are inferred from the claim text.

Facts

Application: 12/232,993Filed 26 Sep 2008 · continuation in part
Priority: FR 03 0050717 Jan 2003
Published: US 2009/0143347 A14 Jun 2009
Granted: 18 Dec 2012
Term ends: Not estimatedThe source records don’t support an estimate.

Classification10 codes

A61K 31/573
Substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone: substituted in position 21, e.g. cortisone,…
A61K 9/0019
Galenical forms characterised by the site of application: injectable compositions; Intramuscular, intravenous, arterial, subcutaneous…
A61K 9/0043
Galenical forms characterised by the site of application: nose
A61K 9/0053
Galenical forms characterised by the site of application: mouth and digestive tract, i.e. intraoral and peroral administration

Family

PCT/FR2004/000086Parent of this continuation-in-part · filed 16 Jan 2004
US 2009/0143347 A1Pre-grant publication · published 4 Jun 2009
Application10/542,495Parent of this continuation-in-part
US 8,034,798 B2Parent of this continuation-in-part
US 2006/0199790 A1Published application
US 8,334,278 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results